11 | It just seems to fit better, especially if a | Sawbuckle | 07/13/2012 11:53:26 AM |
10 | This is starting to get to the point of comical. | holsh | 07/13/2012 11:51:28 AM |
9 | Not only is it hard to watch today; but even | Sawbuckle | 07/13/2012 11:50:47 AM |
8 | I like this site much better than stock house. | holsh | 07/13/2012 11:47:40 AM |
7 | sup | holsh | 07/13/2012 11:42:38 AM |
6 | Historical Shorting | Sawbuckle | 07/13/2012 11:23:37 AM |
5 | Share structure: | Sawbuckle | 07/13/2012 10:58:19 AM |
4 | jumped in at 0012 weeee | rfranke727 | 04/28/2012 12:41:16 PM |
3 | awesome volume eod | rfranke727 | 04/28/2012 12:30:49 PM |
2 | My guess is that this is ready to breakout with | GoGetter | 04/10/2012 12:13:34 PM |
1 | I'm surprised this stock has NO followers or | GoGetter | 03/27/2012 10:50:38 PM |
0 | I think there were about 200 Mil shares added to | RainBow898 | 07/25/2012 9:54:18 AM |
Recent Articles
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors
- Solidarity in Aviation: Airline Workers Support Controllers
- Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
- Promising Outcomes Unveiled from HARMONi-6 Clinical Study
- Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
- Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
- Promising Findings on Subcutaneous Amivantamab for Cancer
- Vivace Therapeutics Reports Promising Results for VT3989 Therapy
- iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
- Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
- New Breakthrough Data from Novartis on Prostate Cancer Treatment
- Transforming Assets: The Role of NB HASH in Digital Wealth
- The Future of Wealth: Bridging Real-World Assets with Blockchain
- Avacta Therapeutics Reveals Promising Phase 1a Results for FAP-Dox
- Significant Phase 1a Trial Findings for Faridoxorubicin
- Major Developments in AI: Insights from Top Tech Executives
- Celebrating Five Years of Innovations at United Imaging's Hub
- International Engagement Highlighted at Financial Forum 2025
- Crypto World Buzzes: Ripple's Fund, Bitcoin's Future & More
- Max Stock Limited Reveals Holdings of Key Parties and Officers
- China's Revolutionary Advances in Solid-State Battery Tech
- Biggest Weekly Losers: Insights on IonQ and Tempus AI Stocks
- Revolutionizing Startup Insight with AI: Startuprad.io's New Tool
- Revolutionizing Patient Care with AI: HDAI's Innovative Approach
- Top Gainers in the Market: D-Wave, Estée Lauder & Others
- Empowering Higher Education Payroll Professionals at EIPC
- SystImmune's Iza-bren Shows Promising Results in Cancer Trial
- Latest Developments in the Auto Industry and Technology Advancements
- RAPT Therapeutics Set to Unveil Key Clinical Findings Soon
- Tech Industry Update: Innovations, Earnings, and Future Trends
- Mutuum Finance Advances Plans for Testnet Launch in 2025
- Replimune Showcases Promising Results for Acral Melanoma
- Exciting Developments in RAPT Therapeutics' Clinical Trials
- Are Aliens Now More Likely Than Bitcoin Reaching $200,000?
- Apple's New F1 Streaming Deal and Exciting Recent Developments
- World Winter Sports Expo 2025: A New Era for the Industry
- Alibaba Cloud Revolutionizes AI with Aegaeon System Efficiency
- Mint Miner Innovates with AI-Powered Cloud Mining Solutions
- China Raises Alarms About US Cyberattacks on Key Services
- Regrets of Kamala Harris: Excluding Elon Musk from EV Event